tiprankstipranks
Trending News
More News >
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market

STRATEC Biomedical (SBS) Financial Statements

Compare
5 Followers

STRATEC Biomedical Financial Overview

STRATEC Biomedical's market cap is currently €289.92M. The company's EPS TTM is €0.13; its P/E ratio is 18.10; and it has a dividend yield of 2.71%. STRATEC Biomedical is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 257.62M€ 270.41M€ 274.63M€ 287.33M€ 250.10M
Gross Profit€ 76.39M€ 68.16M€ 79.49M€ 87.71M€ 68.99M
Operating Income€ 28.18M€ 28.12M€ 42.00M€ 49.63M€ 32.48M
EBITDA€ 47.34M€ 43.16M€ 57.53M€ 66.52M€ 56.72M
Net Income€ 16.02M€ 15.37M€ 29.22M€ 39.96M€ 25.18M
Balance Sheet
Cash & Short-Term Investments€ 48.73M€ 34.22M€ 24.07M€ 48.72M€ 39.15M
Total Assets€ 445.06M€ 466.58M€ 397.50M€ 368.52M€ 331.90M
Total Debt€ 130.53M€ 141.37M€ 87.15M€ 85.30M€ 109.58M
Net Debt€ 83.37M€ 107.84M€ 64.48M€ 38.11M€ 72.02M
Total Liabilities€ 202.53M€ 233.25M€ 172.32M€ 162.77M€ 159.36M
Stockholders' Equity€ 242.53M€ 233.33M€ 225.18M€ 205.76M€ 172.54M
Cash Flow
Free Cash Flow€ 30.52M€ 2.00M€ -8.74M€ 43.24M€ 6.27M
Operating Cash Flow€ 48.71M€ 19.43M€ 10.28M€ 63.47M€ 31.85M
Investing Cash Flow€ -15.97M€ -44.16M€ -19.00M€ -20.13M€ -21.84M
Financing Cash Flow€ -20.30M€ 35.44M€ -14.11M€ -34.33M€ 5.22M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

STRATEC Biomedical Debt to Assets

STRATEC Biomedical Cash Flow

STRATEC Biomedical Forecast EPS vs Actual EPS